BioXcel Therapeutics (BTAI) PT Lowered to $86 at Jefferies on Mixed '501 Data
Tweet Send to a Friend
Jefferies analyst Chris Howerton lowered the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $86.00 (from $94.00) after results from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
